Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

New York Times - Sep 30, 2026

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Read full article

More News

Kick Connect
About Us

Kick Connect publishes a comprehensive overview of the latest news and theories on science & technology. We also report accurate news with a unique perspective on the world around us.